Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1962 1
1967 1
1973 2
1983 1
1987 1
1988 1
1996 1
1999 1
2002 1
2003 1
2006 1
2008 1
2009 6
2010 1
2011 1
2013 4
2014 2
2015 2
2016 5
2017 7
2018 6
2019 6
2020 12
2021 13
2022 13
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Morvan F, Rondeau JM, Zou C, Minetti G, Scheufler C, Scharenberg M, Jacobi C, Brebbia P, Ritter V, Toussaint G, Koelbing C, Leber X, Schilb A, Witte F, Lehmann S, Koch E, Geisse S, Glass DJ, Lach-Trifilieff E. Morvan F, et al. Among authors: ritter v. Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12448-12453. doi: 10.1073/pnas.1707925114. Epub 2017 Nov 6. Proc Natl Acad Sci U S A. 2017. PMID: 29109273 Free PMC article.
Educational Debt and Subspecialty Fellowship Type.
Orr CJ, Turner AL, Ritter VS, Gutierrez-Wu JC, Leslie LK. Orr CJ, et al. Among authors: ritter vs. Pediatrics. 2023 Nov 1;152(5):e2023062318. doi: 10.1542/peds.2023-062318. Pediatrics. 2023. PMID: 37791418 No abstract available.
Highly Biaxially Strained Silicene on Au(111).
Nazzari D, Genser J, Ritter V, Bethge O, Bertagnolli E, Ramer G, Lendl B, Watanabe K, Taniguchi T, Rurali R, Kolíbal M, Lugstein A. Nazzari D, et al. Among authors: ritter v. J Phys Chem C Nanomater Interfaces. 2021 May 13;125(18):9973-9980. doi: 10.1021/acs.jpcc.0c11033. Epub 2021 May 4. J Phys Chem C Nanomater Interfaces. 2021. PMID: 34055129 Free PMC article.
Silicene Passivation by Few-Layer Graphene.
Ritter V, Genser J, Nazzari D, Bethge O, Bertagnolli E, Lugstein A. Ritter V, et al. ACS Appl Mater Interfaces. 2019 Apr 3;11(13):12745-12751. doi: 10.1021/acsami.8b20751. Epub 2019 Mar 25. ACS Appl Mater Interfaces. 2019. PMID: 30864771
Supramolecular Assemblies for Electronic Materials.
Barendt TA, Ball ML, Xu Q, Zhang B, Fowler B, Schattman A, Ritter VC, Steigerwald ML, Nuckolls C. Barendt TA, et al. Among authors: ritter vc. Chemistry. 2020 Mar 23;26(17):3744-3748. doi: 10.1002/chem.202000514. Epub 2020 Mar 2. Chemistry. 2020. PMID: 32031717
Epitaxial Growth of Crystalline CaF2 on Silicene.
Nazzari D, Genser J, Ritter V, Bethge O, Bertagnolli E, Grasser T, Weber WM, Lugstein A. Nazzari D, et al. Among authors: ritter v. ACS Appl Mater Interfaces. 2022 Jul 20;14(28):32675-32682. doi: 10.1021/acsami.2c06293. Epub 2022 Jul 6. ACS Appl Mater Interfaces. 2022. PMID: 35793167 Free PMC article.
105 results